Product Overview
PT-141, or bremelanotide, is a synthetic peptide being studied for its potential to treat low sexual desire in women and erectile dysfunction (ED) in men by stimulating melanocortin receptors.1 It shows promise in enhancing sexual desire and arousal, especially in premenopausal women, and offers an alternative to traditional ED treatments.
